Headquartered in San Diego, California, Ferring Research Institute (FRI) is the global peptide therapeutics research center for Ferring Pharmaceuticals. FRI is committed to building a portfolio of novel, innovative peptide-based drugs and biologicals to address the high unmet medical need for patients in our therapeutic areas of interest. The goal of the Ferring Innovation Grants program is to fund exploratory, discovery and preclinical research to identify novel drug targets that are addressable with peptides and/or proteins, and which are for indications within our core therapeutic areas.
Newsroom
Tuesday, 18 March 2014